Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0000950123-10-051647
Filing Date
2010-05-20
Accepted
2010-05-20 17:26:12
Documents
6

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A y84651sc14d9za.htm SC 14D9/A 906655
2 EX-99.A.17 y84651exv99waw17.htm EX-99.A.17 7951
3 EX-99.A.18 y84651exv99waw18.htm EX-99.A.18 11716
4 GRAPHIC y84651y8465104a.gif GRAPHIC 1814
5 GRAPHIC y84651y8465107.gif GRAPHIC 2371
6 GRAPHIC y84651y8465108.gif GRAPHIC 1631
  Complete submission text file 0000950123-10-051647.txt   936916
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filed by) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-37954 | Film No.: 10848734
SIC: 2835 In Vitro & In Vivo Diagnostic Substances